4
Changes in Ownership
Climb Bio, Inc. Filed Acc 0001415889-24-019946
EVP, R&D AND CSO sold 129,206 shares at an average $7.65 ($988,495)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Morisset Valerie EVP, R&D AND CSO | 2024-07-19 | Sale | −10,201 | $7.09 | $72,325 | 150,322 | D |
| Morisset Valerie EVP, R&D AND CSO | 2024-07-19 | Sale | −50,000 | $7.24 | $362,000 | 100,322 | D |
| Morisset Valerie EVP, R&D AND CSO | 2024-07-22 | Sale | −39,005 | $8.07 | $314,770 | 61,317 | D |
| Morisset Valerie EVP, R&D AND CSO | 2024-07-22 | Sale | −30,000 | $7.98 | $239,400 | 31,317 | D |
| Open-market sales · 129,206 sh · avg $7.65 · $988,495 | |||||||
Loading xslF345X05/form4-07232024_090751.xml…